Literature DB >> 26941450

Current Issues in the Diagnosis and Treatment of Endometrial Carcinoma.

J Stubert1, B Gerber1.   

Abstract

Endometrial carcinoma is the most common carcinoma of the female genital tract. Its most important clinical sign is postmenopausal bleeding. An endometrial biopsy is essential for diagnosis. Treatment decisions are governed by tumour risk assessment and patient comorbidity, which is often present. Pelvic and paraaortic lymph node dissection is unnecessary in low risk cases (definition: pT1 a, G1/2) and adjuvant radiotherapy and systemic treatments are usually avoidable. Treatment of high-risk patients (G3 and/or pT1b) and palliative cases is difficult and not well standardised. New molecular-based subtype classification may help treatment decision making in future.

Entities:  

Keywords:  endometrial carcinoma; endometrial thickness; paraaortic lymph node dissection; postmenopausal bleeding; ultrasound

Year:  2016        PMID: 26941450      PMCID: PMC4771503          DOI: 10.1055/s-0035-1558230

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  46 in total

Review 1.  Endometrial biopsy.

Authors:  T J Zuber
Journal:  Am Fam Physician       Date:  2001-03-15       Impact factor: 3.292

2.  New WHO Classification of Endometrial Hyperplasias.

Authors:  G Emons; M W Beckmann; D Schmidt; P Mallmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-02       Impact factor: 2.915

Review 3.  Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.

Authors:  Ioannis D Gallos; Jason Yap; Madhurima Rajkhowa; David M Luesley; Arri Coomarasamy; Janesh K Gupta
Journal:  Am J Obstet Gynecol       Date:  2012-08-10       Impact factor: 8.661

4.  The role of vaginal hysterectomy in the treatment of endometrial carcinoma.

Authors:  R.J. Lellé; G.W. Morley; W.A. Peters
Journal:  Int J Gynecol Cancer       Date:  1994-09       Impact factor: 3.437

5.  Evaluation of parametrial spread in endometrial carcinoma.

Authors:  Yoh Watanabe; Takao Satou; Hidekatsu Nakai; Tomomaro Etoh; Kensaku Dote; Nahoko Fujinami; Hiroshi Hoshiai
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

6.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

Review 7.  Classification of endometrial carcinoma: more than two types.

Authors:  Rajmohan Murali; Robert A Soslow; Britta Weigelt
Journal:  Lancet Oncol       Date:  2014-06       Impact factor: 41.316

8.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

9.  Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

Authors:  Ian Jacobs; Aleksandra Gentry-Maharaj; Matthew Burnell; Ranjit Manchanda; Naveena Singh; Aarti Sharma; Andy Ryan; Mourad W Seif; Nazar N Amso; Gillian Turner; Carol Brunell; Gwendolen Fletcher; Rani Rangar; Kathy Ford; Keith Godfrey; Alberto Lopes; David Oram; Jonathan Herod; Karin Williamson; Ian Scott; Howard Jenkins; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Simon Leeson; Derek Cruickshank; Steven J Skates; Lesley Fallowfield; Mahesh Parmar; Stuart Campbell; Usha Menon
Journal:  Lancet Oncol       Date:  2010-12-10       Impact factor: 41.316

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  5 in total

Review 1.  Current and Emerging Prognostic Biomarkers in Endometrial Cancer.

Authors:  Kelechi Njoku; Chloe E Barr; Emma J Crosbie
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

2.  Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization.

Authors:  Miao Li; Jia-Lun Song; Ying Zhao; She-Ling Wu; Hong-Bin Liu; Rong Tang; Lei Yan
Journal:  J Zhejiang Univ Sci B       Date:  2017 Nov.       Impact factor: 3.066

3.  miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.

Authors:  Xiaoyuan Lu; Li Jing; Sicong Liu; Haihong Wang; Buze Chen
Journal:  Int J Endocrinol       Date:  2022-06-08       Impact factor: 2.803

4.  Prognosis and Efficacy of Laparoscopic Surgery on Patients with Endometrial Carcinoma: Systematic Evaluation and Meta-Analysis.

Authors:  Jiong Ma; Chunxia Zhou; Jinyan Chen; Xuejun Chen
Journal:  Comput Math Methods Med       Date:  2022-09-22       Impact factor: 2.809

5.  Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.

Authors:  Wenhui Wang; Lijuan Zou; Tiejun Wang; Xiaorong Hou; Lichun Wei; Ke Hu; Zi Liu; Jianli He; Xiaoge Sun; Wei Zhong; Fengju Zhao; Xiaomei Li; Sha Li; Hong Zhu; Zhanshu Ma; Shuai Sun; Meng Jin; Fuquan Zhang
Journal:  BMC Cancer       Date:  2021-07-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.